In a total of 462 studies examining gene abnormal expression involving over 20 cancer types, 23% of them identified abnormally high expression of SOX4 in cancers such as GC, melanoma, glioblastoma, lung cancer, and breast cancer [39–42]. Here, SOX4 is linked to melanoma.